AMRN Q1 2020 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$155M+111.5% YoY

Gross Profit

$120M77.5% margin

Operating Income

-$24M-15.5% margin

Net Income

-$21M-13.3% margin

EPS (Diluted)

$-1.14

QoQ Revenue Growth

+8.2%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$926M

Total Liabilities

$340M

Stockholders' Equity

$586M

Cash & Equivalents

$329M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$155M	$73M	+111.5%
Gross Profit	$120M	$56M	+114.1%
Operating Income	-$24M	-$23M	-5.7%
Net Income	-$21M	-$24M	+15.9%

Revenue Segments

Product

$152M98%

Licensing And Royalty

$3M2%